XM does not provide services to residents of the United States of America.

India's Nifty, Sensex outperform most global markets, behind only Wall Street



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>GRAPHIC-India's Nifty, Sensex outperform most global markets, behind only Wall Street</title></head><body>

By Bharath Rajeswaran

BENGALURU, Sept 20 (Reuters) -India's NSE Nifty 50 .NSEI and S&P BSE Sensex .BSESN are trailing only Wall Street's Nasdaq and S&P 500 as top-performing indexes this year, with analysts expecting the rally to extend into 2025.

The Nifty and Sensex have gained 18.5% and 16.5% respectively in 2024, securing the third and fourth spots among major global bourses.

The Nasdaq .IXIC and S&P .SPX have added approximately 22% and 20.5%, slightly ahead of the Indian benchmarks. Japan's Nikkei 225 .N225 and Germany's DAX .GDAXI follow India, rising 13% and 12%, respectively.

Earlier this week, India's weightage in a key MSCI index topped China for the first time.

"We expect the Fed rate cut to accelerate foreign inflows and create enough momentum in domestic markets to protect against downsides," analysts at Emkay Global said in a note.

India's stock market rally, driven by expectations of policy continuity following national elections in June and a robust growth outlook, gained further momentum after the U.S. Federal Reserve's significantrate cut on Sept. 18.

Foreign portfolio inflows, which had moderated in August, are on course for to hit a six-month high in September.

The rally has pushed the 12-month forward price-to-earnings ratios of the Sensex and Nifty to 23.6 and 24.4, respectively—the highest among emerging markets. Technical indicators show both indexes are now in overbought territory.

Expectations of soft landing for the U.S. economy will also likely boost sectors like information technology and pharma which earn a significant share of their revenue from the U.S., according to analysts.

Realty .NIFTYREAL, autos .NIFTYAUTO, public sector enterprises .NIFTYPSE, pharma .NIPHARM and energy .NIFTYENR are among the top performing sectoral indices so far this year.

Domestic institutional and retail investors have also fueled the stock market buying into all dips.

Domestic institutional investors picked up shares worth a net of 3.23 trillion rupees since the start of the year, according to provisional data from National Stock Exchange.

Mutual funds too have remained net buyers since February 2021 with contributions through the systematic investment plan hitting record highs for 14 months in a row.

This has raised some concerns, with analysts at Jefferies saying the combined domestic inflows through mutual funds, direct participation, insurance and pension funds are "unsustainably high" of $7.5 billion per month between January and August.

The brokerage said it maintained a near-term cautious view on markets, small- and mid-caps.


India's Nifty, Sensex among top four global stock indexes in 2024 https://reut.rs/4gvohJQ

FPI inflows in September set to hit a six-month high https://reut.rs/4gAKh6b

Performance of India's key stock indexes in 2024 so far https://reut.rs/47z571s

India's Nifty 50 closing in on 2023 gains in 2024 https://reut.rs/3MRCsv3


Reporting by Bharath Rajeswaran in Bengaluru; Editing by Nivedita Bhattacharjee

</body></html>

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.